The best GLP-1 pill for weight loss is oral Wegovy (semaglutide 25 mg) for most adults who want an oral treatment. Wegovy tablets are FDA-approved for chronic weight management, have trial evidence in adults with overweight or obesity, and carry an indication to reduce major cardiovascular events in certain adults with established cardiovascular disease.
Foundayo (orforglipron), approved by the FDA in April 2026, may be the better practical choice if convenience matters most. Foundayo is taken once daily with or without food. Wegovy tablets must be taken in the morning on an empty stomach with water, followed by a 30-minute wait before eating, drinking or taking other oral medicines.
Best GLP-1 Pills for Weight Loss at a Glance
| Medication | Best for | How it is taken | Key limitation |
|---|---|---|---|
| Wegovy tablet | Strongest overall evidence and people with established cardiovascular disease | Once daily on an empty stomach; 25 mg maintenance dose | Requires strict morning administration |
| Foundayo | Convenience and easier daily use | Once daily with or without food | Newer medication with less long-term real-world experience |
| Rybelsus | Type 2 diabetes treatment | Once daily on an empty stomach | FDA-approved for diabetes, not specifically for weight loss |
Why Oral Wegovy Is the Best Overall Pick
Wegovy tablets contain oral semaglutide. The FDA-approved maintenance dose for weight reduction is 25 mg once daily after gradual dose escalation. The medication is approved for adults with obesity or adults with overweight plus at least one weight-related condition, such as high blood pressure, type 2 diabetes or high cholesterol.
The OASIS 4 trial evaluated 25 mg oral semaglutide in adults with overweight or obesity who did not have diabetes. It found substantial weight loss over approximately 64 weeks. The trial did not directly compare oral Wegovy with Foundayo.
Wegovy tablets may make more sense if you have:
- Obesity or qualifying overweight
- Established cardiovascular disease
- A preference for semaglutide based on its established clinical history
- The ability to follow fasting and medication-timing instructions
The main drawback is the dosing routine. Take Wegovy tablets with no more than 4 ounces of water. Then wait at least 30 minutes before eating, drinking other beverages or taking other oral medications.
When Foundayo May Be the Better Choice
Foundayo contains orforglipron, a once-daily oral GLP-1 receptor agonist approved by the FDA in April 2026 for chronic weight management. You can take Foundayo with or without food, which makes it easier to fit into a normal morning routine.
Foundayo was evaluated in randomized, placebo-controlled trials lasting 72 weeks. The FDA reported clinically meaningful weight reduction compared with placebo when Foundayo was combined with a reduced-calorie diet and increased physical activity.
Foundayo may suit you better if:
- You cannot reliably take medication before breakfast
- You take several morning medicines
- You want a pill that does not require fasting
- You prefer a newer small-molecule GLP-1 treatment
Foundayo still requires gradual dose escalation. Its maximum approved dose is 17.2 mg once daily. Common adverse reactions include nausea, constipation, diarrhea, vomiting, abdominal discomfort, indigestion, reflux and fatigue.
There is no direct head-to-head trial showing that Foundayo or oral Wegovy produces more weight loss than the other. Cross-trial comparisons are estimates, not definitive rankings.
Is Rybelsus a Good Weight-Loss Pill?
Rybelsus is not the best FDA-approved choice for weight loss because its U.S. indication is type 2 diabetes, not chronic weight management. Rybelsus contains oral semaglutide and may cause weight loss, but using it primarily for weight loss would be an off-label decision for a clinician to consider.
Rybelsus and oral Wegovy both contain semaglutide, but they have different FDA-approved indications, dosing programs and clinical evidence.
Important Safety Considerations
Wegovy tablets and Foundayo share important GLP-1-related warnings. Neither medication should be used by people with a personal or family history of medullary thyroid carcinoma or with Multiple Endocrine Neoplasia syndrome type 2. Both can cause gastrointestinal side effects and carry warnings about pancreatitis, gallbladder disease, dehydration-related kidney injury and severe gastrointestinal reactions.
Medical review is especially important if you:
- Are pregnant or planning pregnancy
- Have severe gastroparesis
- Have a history of pancreatitis or significant gallbladder disease
- Take insulin or medications that increase insulin release
- Have a personal or family history of medullary thyroid carcinoma
- Take multiple oral medications affected by delayed gastric emptying
Foundayo can also affect the absorption of oral medicines. Its prescribing information requires additional contraceptive precautions after starting treatment and after dose increases.
Bottom Line
- Best overall GLP-1 pill for weight loss: Wegovy tablet, oral semaglutide 25 mg
- Best for convenience: Foundayo, orforglipron
- Best if you have established cardiovascular disease: Wegovy tablet, because its label includes cardiovascular risk reduction
- Not the preferred weight-loss pill: Rybelsus, unless a clinician recommends it for an individual with type 2 diabetes
A prescriber should base the choice on your medical history, cardiovascular risk, gastrointestinal tolerance, other medications and ability to follow each dosing schedule.